Pathophysiology-based approaches to deep brain stimulation for Parkinson's disease

基于病理生理学的帕金森病脑深部刺激方法

• 批准号: 10703244
• 负责人: Jerrold L Vitek
• 金额: $ 36.76万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-17 至 2026-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10703244
• 关键词: Affect; Agreement; Algorithms; Anatomy; Area; Basal Ganglia; Biological Markers; Bradykinesia; Cells; Clinical; Cognition; Cognitive; Cortical Synchronization; Coupling; Decision Making; Deep Brain Stimulation; Development; Devices; Disease; Electrocorticogram; Electrophysiology (science); Frequencies; Functional disorder; Future; Globus Pallidus; Goals; High Frequency Oscillation; Imaging Techniques; Individual; Lead; Levodopa; Location; Maps; Microelectrodes; Motor; Movement; Neurodegenerative Disorders; Neurons; Outcome; Parkinson Disease; Pathologic; Patients; Pattern; Performance; Persons; Phase; Phenotype; Physiological; Play; Postoperative Period; Prefrontal Cortex; Preparation; Rest; Role; STN stimulation; Sensory; Severities; Shapes; Short-Term Memory; Site; Structure of subthalamic nucleus; Therapeutic; cognitive function; effective therapy; high resolution imaging; improved; insight; motor disorder

ABSTRACT (Project 1) Parkinson’s disease (PD) is a progressive neurodegenerative disease affecting over 10 million people world- wide. It can be a debilitating disorder and although studied for decades the physiological changes in the basal ganglia thalamocortical (BGTC) circuit that underlie its development remain under debate. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) and internal globus pallidus (GPi) has been a highly effective therapy for many patients with PD, however, the results have been highly variable and may be associated with cognitive compromise in some patients. To advance DBS therapies for PD we require a deeper understanding of the local and network-wide circuit dynamics and their relationship to motor signs and cognitive function. This understanding will provide the rationale for optimizing STN and GPi DBS, targeting specific regions within the STN and GPi, and development of patient-specific DBS based on the patients’ motor signs and cognitive profile. The goals of this study are to advance our understanding of the role of BGTC (subcortical-cortical) and cortical-cortical circuits in the development of PD, the changes that occur with DBS and L-dopa, and to use this understanding to advance current and develop new DBS approaches for its treatment. We will define the relationship between synchronized oscillations, coherence and connectivity within the broader BGTC circuit (STN, GPi, sensory, motor, premotor and dorsolateral prefrontal cortices) to the development of PD motor signs, define their role in motor performance (SA1,2), cognitive function (SA1,2,3), and corresponding changes with DBS, L-dopa and DBS+L-dopa (SA2). By defining the strength and direction of connectivity patterns at rest and during movement we will characterize the role of individual circuits within the BGTC network and define their respective roles in motor performance and cognitive function paving the way for future development of optimization algorithms for DBS that take advantage of this understanding (SA1,2,3,4). By correlating the degree of coherence between multiple single cells and local field potential (LFP) activity we will also advance our understanding of the role of spike-phase locking to the development of motor signs. Through high resolution imaging techniques and parcellation analyses we will define the optimal site for DBS within the STN and GPi (SA2,3,4) correlating motor and cognitive outcomes to biomarker activity and lead location, leading to patient- specific DBS and development of automated programming algorithms based on each patient’s phenotype and lead location. The proposed aims will be conducted using directional DBS leads, multiple independent current controlled (MICC) devices, high resolution imaging and electrophysiological recordings in PD patients with electrocorticography (ECoG) arrays undergoing microelectrode mapping (SA1,3), postoperatively in patients with ECoG arrays and externalized leads (SA2,3), and following optimization of DBS parameters (SA4).

摘要（项目一）